Efficacy and Safety of Bumetanide Oral Liquid Formulation in Children Aged From 2 to Less Than 7 Years Old With Autism Spectrum Disorder.

Condition:   Autism Spectrum Disorder (ASD) Interventions:   Drug: BUMETANIDE/S95008;   Drug: PLACEBO Sponsors:   Institut de Recherches Internationales Servier;   ADIR, a Servier Group company Recruiting

Source: ClinicalTrials.gov - October 23, 2018 Category: Research Source Type: clinical trials